Consultant Neurologist/Medical Director – MS Clinic: 2003 – 2014 Baycrest Centre Toronto
Consultant (Contract): Jan-Mar 2004 Sanofi Canada
Medical Director & Consultant Isotechnika (Now Aurinia): 2002 – 2003
Medical Director / Chief Medical Officer / Executive Committee Wyeth Canada: 1999 – 2002
Organized Coordinated and Chaired Advisory Boards in several therapeutic areas including Transplantation, Mental health/Neuroscience, Women’s Health, Rheumatology, Vaccines, Hemophilia, etc. Liaison with USA headquarters in developing a vaccine for Alzheimer’s disease.
David W. Scheifele, Scott A. Halperin, Bruce Smith, Keith Meloff, Denzyl Duarte- Monteiro. Poster 28. Eighth Annual conference on Vaccine Research. Baltimore May 2005 http://www.nfid.org/conferences/vaccine05/
Assessment of the compatibility of co-administered 7-Valent pneumococcal conjugate, DTaP.IPV/PRP-T Hib and hepatitis B vaccines in infants 2-7 months of age. David W. Scheifele, Scott A. Halperin, Bruce Smith, Keith Meloff, Denzyl Duarte-Monteiro. Vaccine 2006, vol. 24, no12, pp. 2057-2064 [8 page(s) (article)] (33 ref.)
and regulatory to enhance Phase IV performance across all therapeutic areas.
Medical Advisor-Director-Major Part-Time Glaxo Canada: 1996 – 1998
Consultant-Medtronic: 1994 -1995
Associate Medical Director: 1992 – 1995
Ciba-Geigy (Novartis) • Medical/ Marketing interface with respect to Ritalin, Anafranil, Tegretol, Aredia, Estraderm, Habitrol, Voltaren and Voltaren Emugel.
EDUCATION AND PROFESSIONAL BACKGROUND
MD (Honors) – University of Manitoba
Board Certified in Pediatrics – Canada
Board Certified in Neurology – Canada
Adjunct Professor, Pediatric Neurology – University of Western Ontario
Consultant Neurologist, Child & Adult Neurology – University Health Network
Consultant Neurologist – Ministry of Health, Province of Ontario
Consultant Neurologist – Ontario Telemedicine Network
Professor/Director, Pediatric Neurology – New Jersey Neuroscience Institute